Anti-inflammatory effects of inosine in allergic lung inflammation in mice: Evidence for the participation of adenosine A2A and A3 receptors

Purinergic Signalling

Volumn 9, Issue 3, 2013, Pages 325-336

  da Rocha Lapa, Fernanda ^a,d   de Oliveira, Ana Paula Ligeiro ^b   Accetturi, Beatriz Golega ^c   de Oliveira Martins, Isabelli ^c   Domingos, Helory Vanni ^c   de Almeida Cabrini, Daniela ^a   de Lima, Wothan Tavares ^c   Santos, Adair Roberto Soares ^d  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b UNIVERSIDADE NOVE DE JULHO   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Adenosine receptors; Allergy; Inosine; Ovalbumin

Indexed keywords

4 [2 [7 AMINO 2 (2 FURYL) 1, 2, 4 TRIAZOLO [2, 3 A] [1, 3, 5] TRIAZIN 5 YLAMINO] ETHYL] PHENOL; ADENOSINE A2A RECEPTOR; ADENOSINE A3 RECEPTOR; INOSINE; INTERLEUKIN 4; INTERLEUKIN 5; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; CONTROLLED STUDY; CYTOKINE RELEASE; ELISA KIT; EOSINOPHIL; FEMALE; HISTOLOGY; LUNG LAVAGE; LYMPHOCYTE; MACROPHAGE; MAST CELL; MOUSE; NONHUMAN; TREATMENT OUTCOME;

ANIMALS; FEMALE; INFLAMMATION; INOSINE; LUNG; MICE; MICE, INBRED BALB C; RECEPTOR, ADENOSINE A3; RECEPTORS, ADENOSINE A2; RESPIRATORY HYPERSENSITIVITY;

EID: 84883461852     PISSN: 15739538     EISSN: 15739546     Source Type: Journal    
DOI: 10.1007/s11302-013-9351-x     Document Type: Article

References (43)

1. Ralevic V, Burnstock G (1998) Receptors for purines and pyrimidines. Pharmacol Rev 50(3): 413-492.
2. Caruso M, Holgate ST, Polosa R (2006) Adenosine signalling in airways. Curr Opin Pharmacol 6(3): 251-256.
3. Fredholm BB, IJzerman AP, Jacobson KA, Klotz KN, Linden J (2001) International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 53(4): 527-552.
4. Gomez G, Sitkovsky MV (2003) Differential requirement for A2a and A3 adenosine receptors for the protective effect of inosine in vivo. Blood 102(13): 4472-4478.
5. Hasko G, Sitkovsky MV, Szabo C (2004) Immunomodulatory and neuroprotective effects of inosine. Trends Pharmacol Sci 25(3): 152-157.
6. Sitkovsky MV, Ohta A (2005) The 'danger' sensors that STOP the immune response: the A2 adenosine receptors? Trends Immunol 26(6): 299-304.
7. Spicuzza L, Di Maria G, Polosa R (2006) Adenosine in the airways: implications and applications. Eur J Pharmacol 533(1-3): 77-88.
8. Blackburn MR (2003) Too much of a good thing: adenosine overload in adenosine-deaminase-deficient mice. Trends Pharmacol Sci 24(2): 66-70.
9. Cushley MJ, Tattersfield AE, Holgate ST (1983) Inhaled adenosine and guanosine on airway resistance in normal and asthmatic subjects. Br J Clin Pharmacol 15(2): 161-165.
10. Oosterhoff Y, de Jong JW, Jansen MA, Koeter GH, Postma DS (1993) Airway responsiveness to adenosine 5′-monophosphate in chronic obstructive pulmonary disease is determined by smoking. Am Rev Respir Dis 147(3): 553-558.
11. Caruso M, Varani K, Tringali G, Polosa R (2009) Adenosine and adenosine receptors: their contribution to airway inflammation and therapeutic potential in asthma. Curr Med Chem 16(29): 3875-3885.
12. Mortaz E, Folkerts G, Nijkamp FP, Henricks PA (2010) ATP and the pathogenesis of COPD. Eur J Pharmacol 638(1-3): 1-4.
13. Fozard JR, Ellis KM, Villela Dantas MF, Tigani B, Mazzoni L (2002) Effects of CGS 21680, a selective adenosine A2A receptor agonist, on allergic airways inflammation in the rat. Eur J Pharmacol 438(3): 183-188.
14. El-Hashim AZ, Abduo HT, Rachid OM, Luqmani YA, Al Ayadhy BY, Alkhaledi GM (2009) Intranasal administration of NECA can induce both anti-inflammatory and pro-inflammatory effects in BALB/c mice: evidence for A 2A receptor sub-type mediation of NECA-induced anti-inflammatory effects. Pulm Pharmacol Ther 22(3): 243-252.
15. Eltzschig HK (2009) Adenosine: an old drug newly discovered. Anesthesiology 111(4): 904-915.
16. Trams EG, Lauter CJ (1974) On the sidedness of plasma membrane enzymes. Biochim Biophys Acta 345(2): 180-197.
17. Liaudet L, Mabley JG, Soriano FG, Pacher P, Marton A, Hasko G, Szabo C (2001) Inosine reduces systemic inflammation and improves survival in septic shock induced by cecal ligation and puncture. Am J Respir Crit Care Med 164(7): 1213-1220.
18. Hasko G, Kuhel DG, Nemeth ZH, Mabley JG, Stachlewitz RF, Virag L, Lohinai Z, Southan GJ, Salzman AL, Szabo C (2000) Inosine inhibits inflammatory cytokine production by a posttranscriptional mechanism and protects against endotoxin-induced shock. J Immunol 164(2): 1013-1019.
19. Rahimian R, Fakhfouri G, Daneshmand A, Mohammadi H, Bahremand A, Rasouli MR, Mousavizadeh K, Dehpour AR (2010) Adenosine A2A receptors and uric acid mediate protective effects of inosine against TNBS-induced colitis in rats. Eur J Pharmacol 649(1-3): 376-381.
20. Jin X, Shepherd RK, Duling BR, Linden J (1997) Inosine binds to A3 adenosine receptors and stimulates mast cell degranulation. J Clin Invest 100(11): 2849-2857.
21. Liaudet L, Mabley JG, Pacher P, Virag L, Soriano FG, Marton A, Hasko G, Deitch EA, Szabo C (2002) Inosine exerts a broad range of antiinflammatory effects in a murine model of acute lung injury. Ann Surg 235(4): 568-578.
22. Mabley JG, Pacher P, Murthy KG, Williams W, Southan GJ, Salzman AL, Szabo C (2009) The novel inosine analogue INO-2002 exerts an anti-inflammatory effect in a murine model of acute lung injury. Shock 32(3): 258-262.
23. da Rocha Lapa F, da Silva MD, de Almeida Cabrini D, Santos AR (2012) Anti-inflammatory effects of purine nucleosides, adenosine and inosine, in a mouse model of pleurisy: evidence for the role of adenosine A(2) receptors. Purinergic Signal 8(4): 693-704.
24. Sitkovsky MV (2003) Use of the A(2A) adenosine receptor as a physiological immunosuppressor and to engineer inflammation in vivo. Biochem Pharmacol 65(4): 493-501.
25. Hasko G, Cronstein BN (2004) Adenosine: an endogenous regulator of innate immunity. Trends Immunol 25(1): 33-39.
26. Nascimento FP, Figueredo SM, Marcon R, Martins DF, Macedo SJ Jr, Lima DA, Almeida RC, Ostroski RM, Rodrigues AL, Santos AR (2010) Inosine reduces pain-related behavior in mice: involvement of adenosine A1 and A2A receptor subtypes and protein kinase C pathways. J Pharmacol Exp Ther 334(2): 590-598.
27. Riffo-Vasquez Y, Ligeiro de Oliveira AP, Page CP, Spina D, Tavares-de-Lima W (2007) Role of sex hormones in allergic inflammation in mice. Clin Exp Allergy 37(3): 459-470.
28. Proust B, Nahori MA, Ruffie C, Lefort J, Vargaftig BB (2003) Persistence of bronchopulmonary hyper-reactivity and eosiniphilic lung inflammation after anti-IL-5 or IL-13 treatment in allergic BALB/c and IL-4Rα knockout mice. Clin Exp Allergy 33: 119-131.
29. Orihara K, Dil N, Anaparti V, Moqbel R (2010) What's new in asthma pathophysiology and immunopathology? Expert Rev Respir Med 4(5): 605-629.
30. Polosa R, Holgate ST (2006) Adenosine receptors as promising therapeutic targets for drug development in chronic airway inflammation. Curr Drug Targets 7(6): 699-706.
31. Sun CX, Zhong H, Mohsenin A, Morschl E, Chunn JL, Molina JG, Belardinelli L, Zeng D, Blackburn MR (2006) Role of A2B adenosine receptor signaling in adenosine-dependent pulmonary inflammation and injury. J Clin Invest 116(8): 2173-2182.
32. Garcia Soriano F, Liaudet L, Marton A, Hasko G, Batista Lorigados C, Deitch EA, Szabo C (2001) Inosine improves gut permeability and vascular reactivity in endotoxic shock. Crit Care Med 29(4): 703-708.
33. Impellizzeri D, Di Paola R, Esposito E, Mazzon E, Paterniti I, Melani A, Bramanti P, Pedata F, Cuzzocrea S (2011) CGS 21680, an agonist of the adenosine (A2A) receptor, decreases acute lung inflammation. Eur J Pharmacol 668(1-2): 305-316.
34. Huang S, Apasov S, Koshiba M, Sitkovsky M (1997) Role of A2a extracellular adenosine receptor-mediated signaling in adenosine-mediated inhibition of T-cell activation and expansion. Blood 90(4): 1600-1610.
35. Koshiba M, Rosin DL, Hayashi N, Linden J, Sitkovsky MV (1999) Patterns of A2A extracellular adenosine receptor expression in different functional subsets of human peripheral T cells. Flow cytometry studies with anti-A2A receptor monoclonal antibodies. Mol Pharmacol 55(3): 614-624.
36. Garcia GE, Truong LD, Li P, Zhang P, Du J, Chen JF, Feng L (2008) Adenosine A2A receptor activation and macrophage-mediated experimental glomerulonephritis. FASEB J 22(2): 445-454.
37. Polosa R (2002) Adenosine-receptor subtypes: their relevance to adenosine-mediated responses in asthma and chronic obstructive pulmonary disease. Eur Respir J 20(2): 488-496.
38. Livingston M, Heaney LG, Ennis M (2004) Adenosine, inflammation and asthma-a review. Inflamm Res 53(5): 171-178.
39. Holgate ST (2008) Pathogenesis of asthma. Clin Exp Allergy 38(6): 872-897.
40. Galli SJ, Tsai M, Piliponsky AM (2008) The development of allergic inflammation. Nature 454(7203): 445-454.
41. Virag L, Szabo C (2001) Purines inhibit poly(ADP-ribose) polymerase activation and modulate oxidant-induced cell death. FASEB J 15(1): 99-107.
42. Liaudet L, Pacher P, Mabley JG, Virag L, Soriano FG, Hasko G, Szabo C (2002) Activation of poly(ADP-ribose) polymerase-1 is a central mechanism of lipopolysaccharide-induced acute lung inflammation. Am J Respir Crit Care Med 165(3): 372-377.
43. Becker BF, Reinholz N, Ozcelik T, Leipert B, Gerlach E (1989) Uric acid as radical scavenger and antioxidant in the heart. Pflugers Arch 415(2): 127-135.